Urticaria and angioedema
Urticaria (hives) is a common eruption characterized by transient, usually pruritic, wheals due to acute dermal oedema from extravascular leakage of plasma. Angioedema signifies a larger area of oedema involving the dermis and subcutis. A classification is shown in Table 1.
Allergic (IgE mediated) mast cell degranulation | SystemicSkin contact | Food, drugs, latex (aerosols)Animal saliva, pollen, latex |
Non-allergic (non-IgE mediated) mast cell degranulation | Chronic ordinaryPhysicalPharmacological | No cause identifiable (commonest subtype)Dermographism, cholinergic, cold, solar, heat, delayed pressureAspirin, opiates, non-steroidal drugs, food additives, ACE inhibitors (p. 87) |
Autoimmune disease | Systemic lupus erythematosus (p. 80), thyroid antibodies, anti-IgE receptor antibodies, urticarial vasculitis (p. 77) | |
Genetic | C1 esterase inhibitor deficiency (p. 77), mastocytosis (p. 116) | |
Other | Infection, paraneoplastic, skin contact (nettle sting) |
Aetiopathogenesis
IgE-mediated (type I) hypersensitivity (p. 11) is the best understood mechanism; antigen cross-links immunoglobulin (Ig) E molecules on the surface of mast cells, resulting in degranulation with release of vasoactive agents.
Complement activation can produce dermal oedema, as in hereditary angioedema or urticaria associated with circulating immune complexes.
Direct release of histamine from mast cells, in a non-immune manner, is caused by some drugs, e.g. opiates and contrast media.
Blocking of the prostaglandin pathway from arachidonic acid, by some drugs such as aspirin and non-steroidal anti-inflammatory agents, promotes urticaria by accumulating vasoactive leukotrienes.
Anti-IgE receptor (anti-FcεR1) antibodies have been shown to be present in 40% of cases of ‘chronic’ urticaria, which is capable of inducing autoimmune mast cell degranulation.